ClinicalTrials.gg
Drug

Semapimod clinical trials

Also written CNI-1493.

studies test it
4
open now
0
in phase 3
0
first study started
2002

How each study uses semapimod is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Semapimod
4

Development codes

CNI-1493
3

Studies by the year they started

4 studies that test it; most in 2002 (3)

Studies that test semapimod, by start year
YearStudies
20023
20031

By phase

A phase 1/2 study counts in both.

Phase 2
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 0

Ferring Pharmaceuticals (4)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses semapimod is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 4

Codes

What other systems call semapimod · ClinicalTrials.gg INT003882

  • MeSH (NLM) C097256semapimodConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 9SGW2H1K8PSEMAPIMODConfirmed FDA, NLM, Wikidata
  • Wikidata Q7449117semapimodConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C96535SemapimodOne source FDA
  • DrugBank DB12094One source Wikidata

Also registered as semapimod hydrochloride dihydrate (UNII 49H2LZA8OM), semapimod mesylate (UNII 8W415THB21) and semapimod tetrahydrochloride (UNII A16WYQ522A).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.